Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Biotech

Recent news which mentions Biotech

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Greater Winston-Salem Inc. event emphasizes the innovation in City of Arts and Innovation
Tickers INNO
Tags Pharmaceuticals Inno Biotech
From Business Journals
CVRx Touts Long-term Benefits For Barostim In Heart Failure Patients
Tickers CVRX
Tags Health Care Market News CVRX
From Benzinga
Accelerated Approval For Gene Therapies - US Health Regulator Looks To Improve Process
Tickers SRPT
Tags General FDA Benzinga
From Benzinga
Gilead's Flagship CAR T-cell Therapy Shows Improved Overall Survival In Pretreated Lymphoma Patients
Tickers GILD
Tags General GILD Benzinga
From Benzinga
Coya Therapeutics' COYA 302 Treating ALS Proves Effective In Proof-Of-Concept Academic Clinical Study
Tickers COYA
Tags News Biotech Market News
From Benzinga
Selecta, SOBI's Chronic Refractory Gout Program Meets Primary Goal, US Submission Expected Next Year
Tickers BIOVF SELB
Tags Market News Movers Trading Ideas
From Benzinga
Coya Therapeutics Reveals Proof-of-Concept Data From Small Study With ALS Patients
Tickers COYA
Tags Biotech News Movers
From Benzinga
Moderna Wants $130 Per COVID-19 Vaccine Dose, US Health Authorities Warn Of Incurable Deadly Fungal Infection, Elon Musk Wants Interest Rate Cut: Today's Top Stories
Tickers FLT GOOG GOOGL MBGYY
Tags News Top Stories Tech
From Benzinga
Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information
Tickers AZN BNTX GSK JNJ
Tags Health Care AZN Biotech
From Benzinga
Moderna Wants To Charge About $130 Per COVID-19 Vaccine Dose
Tickers BNTX MRNA PFE
Tags Briefs Large Cap COVID/19 Vaccine
From Benzinga
What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years?
Tickers BMY BRTX GILD PFE
Tags Penny Stocks GILD General
From Benzinga
Despite Failed Phase 3 Study, FDA Staff Says Biogen's ALS Drug May Have Clinical Benefit
Tickers BIIB
Tags Biotech News BIIB
From Benzinga
Viewpoint: How will we tackle barriers to rare disease care?
Tags Brian Ashe Pharmaceuticals Insurance
From Business Journals
Triangle science firm beats the odds – extends Series A to $65M
Tickers INNO
Tags Pharmaceuticals Inno Banking & Financial Services
From Business Journals
HLN's Immunization Calculation Engine (ICE) is continually updated to support new COVID-19 recommendations
Tickers ICE
Tags Electronic Health Record United States Health
From PRLog
New Four Year Data For Roche's Evrysdi Reinforces Long-Term Efficacy, Safety Profile In Muscular Atrophy Patients
Tickers RHHBF RHHBY RHHVF
Tags Benzinga Briefs Large Cap
From Benzinga
Daiichi, Zymeworks Terminate Seven Year-Cancer Antibody Pact
Tickers DSKYF DSNKY ZYME
Tags Biotech News Health Care
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.